Cargando…
IMP4 Silencing Inhibits the Malignancy of Lung Adenocarcinoma via ERK Pathway
Our study aimed to elucidate the function of IMP U3 small nucleolar ribonucleoprotein 4 (IMP4) in lung adenocarcinoma (LUAD) and its potential molecular mechanisms. Cell counting kit-8, 5-ethynyl-20-deoxyuridine, flow cytometry, wound healing, and transwell assays were performed to examine the biolo...
Autores principales: | Li, Ruzhen, Han, Zhaohui, Ma, Wei, Zhang, Lin, Zhang, Xiangwei, Jiang, Yuanzhu, Dong, Wei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9617734/ https://www.ncbi.nlm.nih.gov/pubmed/36317123 http://dx.doi.org/10.1155/2022/8545441 |
Ejemplares similares
-
PTS is activated by ATF4 and promotes lung adenocarcinoma development via the Wnt pathway
por: Ma, Wei, et al.
Publicado: (2022) -
USF1-CHCHD4 axis promotes lung adenocarcinoma progression partially via activating the MYC pathway
por: Zhou, Yuhui, et al.
Publicado: (2022) -
IMP3 can predict aggressive behaviour of lung adenocarcinoma
por: Beljan Perak, Renata, et al.
Publicado: (2012) -
RRM2 silencing suppresses malignant phenotype and enhances radiosensitivity via activating cGAS/STING signaling pathway in lung adenocarcinoma
por: Jiang, Xueping, et al.
Publicado: (2021) -
HIGD2A silencing impairs hepatocellular carcinoma growth via inhibiting mitochondrial function and the MAPK/ERK pathway
por: Huang, Kuiyuan, et al.
Publicado: (2023)